loading
Schlusskurs vom Vortag:
$1.33
Offen:
$1.34
24-Stunden-Volumen:
5.53M
Relative Volume:
2.79
Marktkapitalisierung:
$10.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.14M
KGV:
-0.2563
EPS:
-5.97
Netto-Cashflow:
$-28.20M
1W Leistung:
+41.67%
1M Leistung:
+115.16%
6M Leistung:
-58.42%
1J Leistung:
-90.41%
1-Tages-Spanne:
Value
$1.3198
$1.79
1-Wochen-Bereich:
Value
$0.969
$1.79
52-Wochen-Spanne:
Value
$0.65
$26.25

Citius Pharmaceuticals Inc Stock (CTXR) Company Profile

Name
Firmenname
Citius Pharmaceuticals Inc
Name
Telefon
(908) 967-6676
Name
Adresse
11 COMMERCE DRIVE, CRANFORD, NJ
Name
Mitarbeiter
23
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-07
Name
Neueste SEC-Einreichungen
Name
CTXR's Discussions on Twitter

Vergleichen Sie CTXR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CTXR
Citius Pharmaceuticals Inc
1.53 10.94M 0 -39.14M -28.20M -5.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-30 Hochstufung D. Boral Capital Hold → Buy
2021-11-30 Eingeleitet Maxim Group Buy

Citius Pharmaceuticals Inc Aktie (CTXR) Neueste Nachrichten

pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology On Track to Launch Lymphir in US in H2 - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PR Newswire

Jun 17, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Sells 1,126,188 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Citius Oncology enters distribution services agreement with Cardinal Health - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - The Victoria Advocate

Jun 13, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Closes $6M Securities Offering - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

After Major Oncology Conference, All Eyes Turn to Industry Innovation - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces Closing Of Registered Direct Offering Of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules | CTXR Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Secures $15.8M Financing Deal: What This Means for LYMPHIR Commercialization - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Longview News-Journal

Jun 12, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundrais - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharma secures $6 million in stock offering By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundraising Efforts | CTXR Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals Stock Is Falling Tuesday: What's Going On? - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offeri - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offering - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Price Target Lowered, Rating Maint - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals announces registered direct offering of $15.8 million - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharma secures $6 million in stock offering - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offeri - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offering | CTXR Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharma Announces Direct Offering - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals Announces a Registered Direct Offering of - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Given “Buy” Rating at D. Boral Capital - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals expands authorized shares By Investing.com - Investing.com Nigeria

Jun 10, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Pharmaceuticals (CTXR) Receives Continued Buy Rating from Analyst | CTXR Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Pharmaceuticals expands authorized shares - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Pharmaceuticals Stock Is Soaring Monday: What's Going On? - Benzinga

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Signs US Distribution Deal With Cardinal Health for Lymphir - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Cardinal Health (CAH) Partners with Citius Oncology for LYMPHIR Distribution | CAH Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Inks Distribution Services Agreement With Cardinal Health For LYMPHIR - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health | CTXR Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Sells 609,711 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Sells 306,583 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - mx.advfn.com

Jun 04, 2025
pulisher
Jun 03, 2025

Citius Pharmaceuticals Issues $1M Promissory Note to Pagoda - TipRanks

Jun 03, 2025
pulisher
May 29, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Receives $54.50 Consensus Price Target from Brokerages - Defense World

May 29, 2025
pulisher
May 27, 2025

Why Shares of SoundHound AI Are Soaring Today - The Globe and Mail

May 27, 2025
pulisher
May 26, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Cut to Hold at Maxim Group - Defense World

May 26, 2025
pulisher
May 23, 2025

Maxim Group Downgrades Citius Pharmaceuticals (CTXR) - MSN

May 23, 2025
pulisher
May 23, 2025

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

May 23, 2025
pulisher
May 23, 2025

Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim Group - GuruFocus

May 23, 2025

Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):